✦ LIBER ✦

Pharmacodynamic interaction between fenofibrate and the cholesterol absorption inhibitor ezetimibe

✍ Scribed by Kosoglou, T.; Guillaume, M.; Sun, S.; Pember, L.J.C.; Reyderman, L.; Statkevich, P.; Cutler, D.L.; Veltri, E.P.; Affrime, M.B.

Book ID: 118630115
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 124 KB
Volume: 2
Category: Article
ISSN: 1567-5688
DOI: 10.1016/s1567-5688(01)80026-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacodynamic interaction between the

Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin

✍ T. Kosoglou; I. Meyer; B. Musiol; L. Mellars; P. Statkevich; M.F. Miller; P.P. S 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Drug Interactions Between the Immunosupp

Drug Interactions Between the Immunosuppressant Tacrolimus and the Cholesterol Absorption Inhibitor Ezetimibe in Healthy Volunteers

✍ Oswald, S; Nassif, A; Modess, C; Keiser, M; Ulrich, A; Runge, D; Hanke, U; Lütjo 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 161 KB

Disposition of the cholesterol absorptio

Disposition of the cholesterol absorption inhibitor ezetimibe in mdr1a/b (−/−) mice

✍ Stefan Oswald; Christiane Koll; Werner Siegmund 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

The lipid lowering agent ezetimibe (EZ) and its intestinally formed glucuronide (GLUC) were shown to be substrates of the efflux transporters P-glycoprotein (P-gp) and the multidrug resistance associated protein 2 (MRP2) which markedly influences the disposition and efficacy of EZ in man. This study

The novel cholesterol absorption inhibit

The novel cholesterol absorption inhibitor, ezetimibe, selectively inhibits the intestinal absorption of free cholesterol in the presence and absence of exocrine pancreatic function

✍ M. van Heek; C. Farley; D. Compton; L. Hoos; H. Davis 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 172 KB

The potent cholesterol absorption inhibi

The potent cholesterol absorption inhibitor, ezetimibe, ablates hypercholesterolemia and hypertriglyceridemia in a model of combined hyperlipidemia

✍ M. van Heek; T. Austin; J. Cook; C. Farley; G. Tetzloff; H. Davis 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Pharmacokinetic and Pharmacodynamic Inte

Pharmacokinetic and Pharmacodynamic Interactions Between the Immunosuppressant Sirolimus and the Lipid-Lowering Drug Ezetimibe in Healthy Volunteers

✍ Oswald, S; Nassif, A; Modess, C; Keiser, M; Hanke, U; Engel, A; Lütjohann, D; We 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 156 KB